Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Increased Body Temperature01:25

Increased Body Temperature

1.7K
A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
1.7K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

38
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
38
Patterns of Fever01:26

Patterns of Fever

3.0K
Before understanding the types and patterns of fever, it is essential to know its phases.
3.0K
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

44
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
44

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aminoglycosides induce immune activation but is insufficient for systemic viral control: a double-blind randomized-controlled clinical trial.

Communications medicine·2026
Same author

Influence of obesity on susceptibility to systemic symptoms and host responses to orthoflaviviral infection: a prospective observational study using yellow fever vaccine to simulate acute infection.

EBioMedicine·2026
Same author

Addressing Knowledge, Attitudes and Practices Toward Dengue Fever, Vector Control, and Vaccine Acceptance Among the General Population in Singapore.

Tropical medicine and infectious disease·2026
Same author

Neutralizing antibody titers do not predict T cell response to live-attenuated orthoflaviviral vaccination in humans.

Vaccine·2026
Same author

Dengue infection elicits skin tissue-resident and circulating CD8<sup>+</sup> T cells associated with protection from hospitalization.

Science advances·2026
Same author

Urinary Neutrophil Mediators as Predictive Biomarkers for Severe Dengue in Adults.

Open forum infectious diseases·2026
Same journal

Diagnostic challenges in re-emerging rickettsioses: why current tools fall short.

Clinical microbiology reviews·2026
Same journal

Current progress in developing mRNA-lipid nanoparticle vaccines against human bacterial pathogens.

Clinical microbiology reviews·2026
Same journal

The gut microbiome and colorectal cancer.

Clinical microbiology reviews·2026
Same journal

Influence of fungi on epithelial homeostasis and role in inflammatory diseases.

Clinical microbiology reviews·2026
Same journal

Coxsackievirus A6 on the rise: epidemiology, pathogenicity, evolutionary dynamics, and antiviral strategy.

Clinical microbiology reviews·2026
Same journal

Intravesical therapies for catheter-associated urinary tract infections: current approaches and future directions.

Clinical microbiology reviews·2026
See all related articles

Related Experiment Video

Updated: Sep 9, 2025

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.7K

Dengue and severe dengue.

Shirin Kalimuddin1,2, Po Ying Chia3,4,5, Jenny G Low1,2,6

  • 1Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.

Clinical Microbiology Reviews
|September 5, 2025
PubMed
Summary
This summary is machine-generated.

Dengue virus (DENV) is expanding globally, affecting adults and requiring new countermeasures. This review explores dengue pathogenesis, immunity, and antiviral development to combat the growing global burden.

Keywords:
adult denguedenguedengue virus (DENV)host factorshost responseimmunitytherapeuticsvaccines

More Related Videos

Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection
06:00

Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection

Published on: January 26, 2024

1.5K
Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
08:36

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

32.1K

Related Experiment Videos

Last Updated: Sep 9, 2025

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.7K
Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection
06:00

Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection

Published on: January 26, 2024

1.5K
Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
08:36

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

32.1K

Area of Science:

  • Virology and Immunology
  • Infectious Diseases
  • Public Health

Background:

  • Dengue, a mosquito-borne viral illness caused by four serotypes of dengue virus (DENV-1 to -4), is increasingly prevalent globally.
  • The geographic range of DENV and its Aedes mosquito vector is expanding into non-endemic regions, including North America and Europe.
  • Dengue incidence is rising in adults, posing unique management challenges, particularly for older populations.

Purpose of the Study:

  • To review the molecular mechanisms of dengue pathogenesis from virological and immunological viewpoints.
  • To discuss challenges and opportunities in developing antiviral therapies for dengue.
  • To explore new insights into dengue immunity to guide vaccine deployment strategies.

Main Methods:

  • Literature review of molecular pathogenesis, virology, and immunology of dengue.
  • Analysis of current vaccine efficacy and limitations.
  • Discussion of hurdles in antiviral drug development for dengue.

Main Results:

  • Understanding dengue pathogenesis is crucial for developing effective antiviral treatments and vaccines.
  • Current dengue vaccines show limitations, necessitating complementary control measures.
  • Advances in understanding dengue immunity can optimize the use of existing and future vaccines.

Conclusions:

  • Vaccination alone is insufficient to halt the global expansion of dengue.
  • Antiviral drugs are essential for comprehensive dengue control strategies.
  • Integrated approaches combining antivirals and optimized vaccine deployment are needed to reduce the global dengue burden.